Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Theresa Lydon: Prevention of future deaths report

AI Summary
  • Inconsistent consultant correspondence made required GP actions unclear, causing failure to implement prescribed treatment and risking preventable deaths.
  • Current practice prevents specialists issuing immediate prescriptions at diagnosis, delaying essential treatment initiation and jeopardising patient outcomes.
  • Lack of timely cross trust access to patient records meant clinicians could not review recent admissions, creating risk of missed severity and adverse outcomes.
Summarise with AI (MRCPsych/FRANZCP)

Date of report: 21/04/26

Ref: 2026-0244

Deceased name: Theresa Lydon

Coroner name: James Thompson 

Coroner Area: Gateshead & South Tyneside

This report is being sent to: Department of Health and Social Care

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS
THIS REPORT IS BEING SENT TO:
Secretary of State for Health and Social Care
1 CORONER 
I am James Thompson, Assistant Coroner for Gateshead & South Tyneside. 
2 CORONER’S LEGAL POWERS 
I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009,  Regulations 28 and 
http://www.legislation.gov.uk/ukpga/2009/25/schedule/5/paragraph/7 
http://www.legislation.gov.uk/uksi/2013/1629/part/7/made 
3 INVESTIGATION AND INQUEST 
On 26 September 2022 I commenced an investigation into the death of Theresa Lydon. The investigation concluded at the end of the Inquest on 16th April 2026. 
A Narrative Conclusion with a finding of neglect was made. 
1a. Intra-Abdominal Haemorrhage 
1b. Complications of Subtotal Colectomy Operation for Ulcerative Colitis (8.9.22) 
II. Heparin Treatment for Pulmonary Thromboemboli 
4 CIRCUMSTANCES OF THE DEATH 
Mrs Theresa Lydon was diagnosed with ulcerative colitis in May 2021 and prescribed  Balsalazide to treat this condition. This drug was not issued to her until June 2022. The  period the drug was taken was limited once it was prescribed. The evidence does not allow  a determination on what part it’s omission during this period made in her death. 

She was not able to access support from the Inflammatory Bowel Disease nurses in the  community after her diagnosis in May 2021 as a referral to the service was not progressed  and subsequently due to her admission to hospital before she attended a scheduled  appointment set for September 2022. It cannot be said on the evidence if this then  contributed to her death. 

Mrs Lydon suffered with ongoing continuous severe Ulcerative Colitis on the evidence from  July 2022 until her death, she presented to hospital on four occasions during this period.  

On the first occasion the severe Ulcerative Colitis was recognised as was an infection.  Treatment was commenced for both the Ulcerative Colitis and the infection. She was  discharged once improved, but it was accepted her severe Ulcerative Colitis was still  present and further treatment was likely to be necessary. 

She was readmitted to hospital on three occasions in August 2022. The significance of her  severe Ulcerative Colitis was not fully appreciated by those treating her on these admissions and was not definitely recognised until the fourth and final admission to 
hospital. 

The absence of repeated blood tests during her admission to hospital between 8-15 August 2022 prevented those treating her from identifying the severity of her illness and  adopting treatment which on the evidence would have prolonged her life. This contributed 
to her death. 

By the time of her final admission to hospital, opportunities to administer alternative treatment in the form of a biological treatment as opposed to surgery were ineffective. She  was severely debilitated by lengthy hospital admissions, her medical condition and treatment, which made surgery the only available treatment available to her and was seen as a very high risk procedure for those reasons. 
Mrs Theresa Lydon died on 18th September 2022 at South Tyneside District General Hospital, South Shields from an Intra Abdominal Haemorrhage.  

This directly arose from recognised complications from necessary and appropriate surgery to address her pre-existing Ulcerative Colitis.  
The use of anti-coagulation to address the risk of a Pulmonary Thromboemboli contributed  to her deterioration and death. It was an appropriate treatment to prevent her death from a  Pulmonary Embolism. 

The complications she suffered due to the surgery were well known and recognised by those treating her. The surgery which was undertaken was an attempt to prolong her life which despite this caused her death in concert with her Ulcerative Colitis.  

Death contributed to by neglect. 

5 CORONERS CONCERNS 
During the course of the Inquest the evidence revealed matters giving rise to concern. In my  opinion there is a risk that future deaths will occur unless action is taken. In the circumstances it is my statutory duty to report to you.  

The MATTERS OF CONCERN are as follows. 
(1) During the course of the inquest it was established Mrs Lydon was diagnosed with a  condition and treatment was prescribed in the form of a repeat prescription drug in May  2021. The diagnosing consultant set out the treatment plan in a letter to her GP and the  format of the letter was such it was difficult for the receiving GP to see what actions were 
required by him.  
This is compounded when paper correspondence is routinely scanned and emailed by  administrators and the GP is ‘drawn’ to certain sections of the document by the administrators. It was remarked in evidence by the GP that all consultants seem to format 
their correspondence differently and there is no uniform format so a GP can see clearly at 
the outset what the treatment plan is and what action needs to be taken.  

Evidence from the Hospital Trust in question stated they had changed the format of this 
type of correspondence to make it easier to identify the actions to be taken. In Mrs Lydon’s  case, the drug she was prescribed in May 2021 was not identified from the correspondence and was supplied to her in June 2022 when the situation was discovered.  Whilst a remedy has been implemented locally I have a concern that nationally there is a 
risk of future deaths if important correspondence contained treatment plans is not clearly  communicated to those responsible for implementing them. 

(2) Evidence was given at inquest that when a diagnosis is made by a specialist in a  secondary care setting, if drugs are to be prescribed that must be undertaken by the  patient’s GP. It was confirmed that the current practice does not allow for a specialist to 
issue a prescription for the required drugs at the point of diagnosis and then instruct the  patient’s GP to continue the process. In Mrs Lydon’s case this would have ensured she  received the clinically indicated drugs immediately.  

(3) On Mrs Lydon’s admission to hospital in Gateshead in July 2022 certain investigations,  treatments and diagnosis were made. She was then discharged and returned to hospital in South Tyneside, a neighbouring NHS Trust in August for what amounted to a further 3  hospital admissions there before her death. Evidence was heard that the doctors in South  Tyneside whilst aware of her recent admission in Gateshead could not access her medical  records for that admission. They requested them in August, but they were not supplied 
until November, after she had died. 

I understand much work regionally has been undertaken since 2022 with North East  England based NHS Trusts to make ‘real time’ access to patient records possible, but  whilst improved it is not complete and this is also a national issue I understand.  

Given the two hospitals Mrs Lydon was a patient in are only 6 miles apart it raises a  concern that doctors attending Mrs Lydon in one location are denied access to another  hospital records so close at hand and I understand this is not a position unique to these  hospitals. To me, the inability of doctors to promptly access a patient’s medical records  from other NHS Trusts to provide the best possible care creates a risk of future deaths. 

6 ACTION SHOULD BE TAKEN 
In my opinion action should be taken to prevent future deaths and I believe you have the  power to take such action 
7 YOUR RESPONSE 
You are under a duty to respond to this report within 56 days of the date of this report, namely by 16 June 2026. 

Your response must contain details of action taken or proposed to be taken, setting out  timetable for action. 

8 COPIES AND PUBLICATION 
I have sent a copy of my report to the Chief Coroner and to the following Interested Persons,  the family of Mrs Lydon, South Tyneside & Sunderland NHS Foundation Trust, Gateshead  Health NHS Foundation Trust, East Wing Surgery, [REDACTED]. I have also sent it  to Care Quality Commission who may find it useful or of interest. 

I am also under a duty to send the Chief Coroner a copy of your response. 

The Chief Coroner may publish either or both in a complete or redacted or summary form. 

He may send a copy of this report to any person who he believes may find it useful or of  interest. You may make representations to me, the Coroner, at the time of your response,  about the release or the publication of your response by the Chief Coroner.  

9 Date: 21 April 2026

The post Theresa Lydon: Prevention of future deaths report appeared first on Courts and Tribunals Judiciary.

Document this CPD

Share Evidence Blueprint

QR Code

Search Google Scholar

Save as PDF

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review